指南与共识主动脉疾病

ESVS 2025 升主动脉腔内修复临床实践共识声明

Editor's Choice - European Society for Vascular Surgery (ESVS) 2025 Clinical Practice Consensus Statement on Ascending Thoracic Endovascular Aortic Repair.
指南 / 共识 · Eur J Vasc Endovasc Surg · 2025-05-21

该共识针对升主动脉疾病(包括A型主动脉夹层、A型壁内血肿、梭形动脉瘤、假性动脉瘤和穿透性主动脉溃疡)的腔内修复(aTEVAR)制定推荐。通过系统文献综述和名义组技术结合结构化德尔菲法形成共识声明,涵盖患者选择、风险分层、手术规划、术中策略和术后管理,强调aTEVAR可作为高手术风险患者的选择,并指出证据缺口和未来研究方向。

要点

  • aTEVAR可作为经选择的升主动脉疾病患者的治疗选择,尤其适用于高手术风险患者。
  • 共识涵盖患者选择、风险分层、手术规划(如锚定区和支架尺寸)、术中策略及术后管理。
  • 强调多学科护理以减少临床实践差异,并指出需进一步研究优化技术、器械数据和长期结局。

核心结论

  • 该文件为aTEVAR作为经选择的升主动脉疾病患者的治疗选择提供基于专家共识的指导,尤其适用于高手术风险患者。
  • 通过提供标准化推荐和强调多学科护理,旨在减少临床实践差异、提高手术安全性并改善患者结局。
  • 未来研究应关注手术技术优化、器械特异性数据、长期结局、患者选择改进以及aTEVAR与开放修复匹配队列的直接比较。

研究设计与样本

  • 制定机构为欧洲血管外科学会(ESVS),采用预定义标准提出最相关临床问题,并进行系统文献综述。
  • 共识声明采用名义组技术制定,包括结构化德尔菲型方法,涉及两次在线会议、三轮调查和一次多学科专家小组最终面对面会议。

主要发现

  • 共识文件就aTEVAR提供推荐,涉及患者选择、风险分层、手术规划(如锚定区和支架移植物尺寸)、术中策略和术后管理。
  • 文件还强调了证据缺口并确定了需要进一步研究的领域。

临床怎么用

  • 原文未据此给出具体推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Diseases of the ascending thoracic aorta, including type A aortic dissection, type A intramural haematoma, fusiform aneurysm, pseudoaneurysms, and penetrating aortic ulcer, pose significant management challenges due to the complex anatomy and high pressure haemodynamics of the ascending aorta. While open surgical repair is the gold standard, efforts to improve access to therapy and reduce invasiveness have driven interest in thoracic endovascular aortic repair adapted for the ascending aorta (aTEVAR). However, the lack of evidence has led to variability in patient selection, procedural approaches, and outcomes. This consensus document aims to provide recommendations on the use of aTEVAR for the treatment of ascending thoracic aortic diseases. METHODS: Pre-defined criteria were applied to develop the most relevant clinical questions, and a systematic literature review was performed. Consensus statements were developed using a nominal group technique, including structured Delphi type methodology involving two online meetings, followed by three survey rounds and a final in person meeting of the multidisciplinary panel of experts. RESULTS: The consensus document provides aTEVAR recommendations in relation to topics including patient selection, risk stratification, procedural planning (e.g., landing zones and stent graft sizing), intra-operative strategies, and post-operative management. The document also highlights gaps in evidence and identifies areas requiring further research. CONCLUSION: This document provides expert consensus based guidance on aTEVAR as a treatment option for selected patients with ascending thoracic aortic diseases, particularly those at high surgical risk. By providing standardised recommendations and emphasising multidisciplinary care, the document aims to reduce variability in clinical practice, enhance procedural safety, and improve patient outcomes. Future research should focus on optimisation of procedural techniques, device specific data, long term outcomes, improving patient selection, and direct comparison of aTEVAR with matched cohorts undergoing open repair.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Trimarchi S, Czerny M, Haulon S, et al. Editor's Choice - European Society for Vascular Surgery (ESVS) 2025 Clinical Practice Consensus Statement on Ascending Thoracic Endovascular Aortic Repair. Eur J Vasc Endovasc Surg. 2025. PMID: 40409456. doi:10.1016/j.ejvs.2025.05.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。